Exelixis
EXEL
#1694
Rank
C$16.49 B
Marketcap
C$61.28
Share price
-0.02%
Change (1 day)
21.27%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.91 Billion

According to Exelixis's latest financial reports the company's total liabilities are C$0.91 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exelixis - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$1.00 B12.18%
2023-12-31C$0.89 B13.74%
2022-12-31C$0.79 B53.05%
2021-12-31C$0.51 B57.01%
2020-12-31C$0.32 B26.24%
2019-12-31C$0.26 B42.01%
2018-12-31C$0.18 B-60.55%
2017-12-31C$0.46 B-31.58%
2016-12-31C$0.68 B3.69%
2015-12-31C$0.65 B29.1%
2014-12-31C$0.50 B9.28%
2013-12-31C$0.46 B10.17%
2012-12-31C$0.42 B37.18%
2011-12-31C$0.30 B-47.73%
2010-12-31C$0.58 B10.36%
2009-12-31C$0.53 B-4.15%
2008-12-31C$0.55 B70.87%
2007-12-31C$0.32 B-8.19%
2006-12-31C$0.35 B10.68%
2005-12-31C$0.32 B10.93%
2004-12-31C$0.28 B13.51%
2003-12-31C$0.25 B-1.2%
2002-12-31C$0.25 B47.9%
2001-12-31C$0.17 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
GlaxoSmithKline
GSK
C$84.66 B 9,145.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
C$91.21 B 9,861.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$107.25 B 11,612.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$108.15 B 11,711.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$111.24 B 12,047.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$156.85 B 17,028.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$159.74 B 17,345.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
C$58.48 M-93.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C$0.10 B-89.08%๐Ÿ‡บ๐Ÿ‡ธ USA